Quantcast

Latest Sequenom Inc. Stories

2014-09-22 08:27:50

SAN DIEGO, Sept. 22, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that its wholly owned subsidiary, Sequenom Laboratories, presented patient clinical data substantiating the performance of its MaterniT21(® )PLUS noninvasive prenatal test (NIPT) in the laboratory. An ad hoc analysis of 185,000 samples from patients at high-risk for fetal chromosome aneuploidy demonstrated stable positivity rates...

2014-09-03 08:33:50

SAN DIEGO, Sept. 3, 2014 /PRNewswire/ -- Edico Genome today announced that Sequenom, Inc., a life sciences company that provides innovative genetic analysis solutions, purchased an Edico Genome DRAGEN(TM) Bio-IT Processor. The DRAGEN Bio-IT Processor is the world's first next-generation sequencing bioinformatics application-specific integrated circuit (ASIC), which is embedded on a PCIe form factor card and accompanied with software as a Platform-as-a-Service (PaaS) platform. The two...

2014-09-02 08:28:54

SAN DIEGO, Sept. 2, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the Company's participation at the 2014 Morgan Stanley Global Healthcare Conference at the Grand Hyatt in New York, NY on September 8 -10, 2014. William Welch, Chief Executive Officer, and Carolyn Beaver, Chief Financial Officer, will present on Monday, September 8, beginning at 9:20 a.m. ET to provide an overview of and...

2014-08-05 08:32:35

SAN DIEGO, Aug. 5, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the Company's participation at the 2014 Wedbush Securities Life Sciences Management Access Conference at Le Parker Meridien in New York, NY on August 12-13, 2014. William Welch, President and Chief Operating Officer, will present on Tuesday, August 12, beginning at 4:15 p.m. ET to provide an overview of and update on the...

2014-07-29 16:27:48

62% Revenue Growth as Reimbursement and Testing Volumes Improve SAN DIEGO, July 29, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $39.8 million for the second quarter of 2014, an increase of 62% compared to revenues of $24.5 million for the second quarter of 2013. The Bioscience business segment, which was sold on May 30, 2014, has been accounted for as a discontinued...

2014-07-29 16:27:45

SAN DIEGO, July 29, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company that provides innovative genetic analysis solutions, and Mayo Medical Laboratories (MML), the third-largest provider of esoteric laboratory services in the United States, have announced a license agreement for noninvasive prenatal testing patents and applications. "We have great appreciation for Mayo Clinic's commitment to research, innovation, and patient care, and we welcome the...

2014-07-22 08:30:52

SAN DIEGO, July 22, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced its wholly owned subsidiary, Sequenom Laboratories, will soon begin reporting on the presence of three additional clinically relevant subchromosomal microdeletions as part of the Enhanced Sequencing Series (ESS) for its MaterniT21(TM) PLUS laboratory-developed test. The microdeletions added include 11q deletion (Jacobsen...

2014-07-15 08:27:35

SAN DIEGO, July 15, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced it will report financial results for the second quarter of 2014 after closing of the NASDAQ Global Market on Tuesday, July 29, 2014. A conference call hosted by William Welch, Chief Executive Officer, and other members of senior management will take place on the same day at 5:00 p.m. EDT (2:00 p.m. PDT) and will be webcast...

2014-06-19 08:28:14

SOPHIA ANTIPOLIS, France, and SAN DIEGO, June 19, 2014 /PRNewswire/ -- Nicox S.A. (NYSE Euronext Paris: COX), the international ophthalmic company, and Sequenom, Inc. (NASDAQ:SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that Nicox's subsidiary, Nicox Inc. is launching expanded access to Sequenom Laboratories' RetnaGene(TM) portfolio of laboratory-developed genetic tests in the United States (U.S.). The RetnaGene portfolio includes...

2014-06-19 08:25:52

LONDON, June 19, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Prenatal Testing Market in the US 2014-2018 http://www.reportbuyer.com/pharma_healthcare/diagnostics/prenatal_testing_market_us_2014_2018.html TechNavio's analysts forecast the Prenatal Testing market in the US to grow at a CAGR of 5.43 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of fetal health-related...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'